Möchten Sie immer auf dem neuesten Stand bleiben?

Cerenome Launches as an Integrated CNS Oncology Company

Reported positive results from the Phase 2b clinical trial of imaging agent RAD 101, showing 93% of evaluable patients treated with RAD 101 achieved the primary endpoint  Plans to initiate Phase 3...

New York City, July 30, 2026 (GLOBE NEWSWIRE) --   In July 2026, ColestZen announced the introduction of its daily capsule formula created to support healthy cholesterol levels, cardiovascular...

WOBURN, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today...

Kehoe Law Firm, P.C. investigating potential securities claims on behalf of investors of Capricor Therapeutics (NASDAQ: CAPR).

First Streaming and Cloud Services agreement drives Q2 results above outlookAnnualized recurring revenue1 at all-time high of $626 million, up 13% YoYCompany raises full year 2026 revenue outlook by...

Total Revenue Increased 22% to $77.5 Million, with MACI Revenue Growth of 23% Net Income of $2.2 Million and Free Cash Flow of $14.3 Million Full-Year 2026 Revenue Guidance Raised to $330 to $340...

STAT3 acts as a convergent node downstream of multiple signaling pathways implicated in ulcerative colitis (UC), integrating immune dysregulation, inflammation and tissue remodeling  More than 70% of...

PETAH TIKVA, Israel, July 30, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...